Synthesis and Molecular Properties of Nerve Agent Reactivator HLö‑7 Dimethanesulfonate
The threat of a deliberate release of chemical nerve agents has underscored the need to continually improve field effective treatments for these types of poisonings. The oxime containing HLö-7 is a potential second-generation therapeutic reactivator. A synthetic process for HLö-7 is detailed with...
Saved in:
Published in: | ACS medicinal chemistry letters Vol. 10; no. 5; pp. 761 - 766 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Chemical Society
09-05-2019
American Chemical Society (ACS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The threat of a deliberate release of chemical nerve agents has underscored the need to continually improve field effective treatments for these types of poisonings. The oxime containing HLö-7 is a potential second-generation therapeutic reactivator. A synthetic process for HLö-7 is detailed with improvements to the DIBAL reduction and ion exchange steps. HLö-7 was visualized for the first time within the active site of human acetylcholinesterase and its relative ex vivo potency confirmed against various nerve agents using a phrenic nerve hemidiaphragm assay. |
---|---|
Bibliography: | DOE - OTHER |
ISSN: | 1948-5875 1948-5875 |
DOI: | 10.1021/acsmedchemlett.9b00021 |